Thursday, March 26, 2026
Home Tags USFDA approval

Tag: USFDA approval

Zydus receives final approval from USFDA for Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial
Brands in Conversation

Zydus receives final approval from USFDA for Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial

Passionate in Marketing -
0
Zydus receives final approval from USFDA for Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial
Brands in Conversation

Zydus receives final approval from USFDA for Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial

Passionate in Marketing -
0
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Ticagrelor Tablets, 90 mg and Tentative Approval for Ticagrelor Tablets, 60 mg
Brands in Conversation

Alembic Pharmaceuticals Limited receives USFDA Final Approval for Macitentan Tablets

Passionate in Marketing -
0
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Carbamazepine Extended-Release Tablets.
Brands in Conversation

Alembic Pharmaceuticals Limited announces USFDA Final Approval for Carbamazepine Extended-Release Tablets.

Author -
0
Zydus receives final approval from USFDA for Celecoxib Capsules, 50 mg, 100 mg, 200 mg, and 400 mg
Brands in Conversation

Zydus receives final approval from USFDA for Celecoxib Capsules, 50 mg, 100 mg, 200 mg, and 400 mg

Author -
0
Zydus Receives Final Approval From USFDA For Glatiramer Acetate Injection, The Generic Version Of Copaxone® 20 Mg/Ml, 40 Mg/Ml, Single-Dose Prefilled Syringes
Brands in Conversation

Zydus Receives Final Approval From USFDA For Glatiramer Acetate Injection, The Generic Version Of Copaxone® 20 Mg/Ml, 40 Mg/Ml, Single-Dose Prefilled Syringes

Author -
0
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Ticagrelor Tablets, 90 mg and Tentative Approval for Ticagrelor Tablets, 60 mg
Brands in Conversation

Alembic Pharmaceuticals Limited announces USFDA Final Approval for Ticagrelor Tablets, 90 mg and Tentative Approval for Ticagrelor Tablets, 60 mg

Author -
0
Zydus receives final approval from USFDA for Ibuprofen and Famotidine Tablets, 800 mg/26.6 mg
Brands in Conversation

Zydus receives final approval from USFDA for Ibuprofen and Famotidine Tablets, 800 mg/26.6 mg

Passionate in Marketing -
0
Granules Strengthens ADHD Portfolio with FDA Approval for Lisdexamfetamine Dimesylate Capsules
Brands in Conversation

Granules Strengthens ADHD Portfolio with FDA Approval for Lisdexamfetamine Dimesylate Capsules

Passionate in Marketing -
0
Granules India Limited Announces FDA Approval for ADHD Treatment, Addressing Drug Shortages in the U.S.
Brands in Conversation

Granules India Limited Announces FDA Approval for ADHD Treatment, Addressing Drug Shortages in the U.S.

Passionate in Marketing -
0
12Page 1 of 2

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

Passionate in Marketing is promoted by i-miRa Knowledge Solutions, a company founded in 2010 to foster various business units dedicated to creating, disseminating, and managing knowledge-based products, services, and solutions. These offerings cater to corporate entities, startups, and academic institutions alike.

Contact : [email protected]

FOLLOW US

© 2026 | Passionate In Marketing |All Rights Reserved | Privacy Policy